Our immunofluorescence studies revealed notable differences in tau and Aβ levels in the hippocampal regions of 3xTg-AD mice treated with TAC (0.1 mg/kg, i.p.)daily for 14 days compared to those receiving the vehicle. Here, MAPT is linked to Alzheimer disease.